RxDoctor Payments Data

Donald Stone, DO

Family Medicine · Stillwater, PANPI 1417992421

Payments from drug & device makers

$705in general payments, 2019–2025

Across 35 payments — averaging $20.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$191
  • Bayer$95
  • AstraZeneca$68
  • Exact Sciences$52
  • Eisai Inc.$45
  • Alkermes, Inc.$32
  • plus $223 from 11 others

What the payments were for

  • Food & beverage$705100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$705 in reported general payments places this provider in the 60th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$26,884
Medicare patients
155
Services billed
578

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban61$61,109
OzempicSemaglutide34$41,663
JardianceEmpagliflozin45$34,057
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$23,862
XareltoRivaroxaban17$21,439
MounjaroTirzepatide11$15,122
MyrbetriqMirabegron22$14,745
TradjentaLinagliptin26$14,040
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$9,380
Fluticasone-SalmeterolFluticasone Propion/Salmeterol25$5,021
Advair HfaFluticasone Propion/Salmeterol15$4,905
SymbicortBudesonide/Formoterol Fumarate14$4,358
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$3,220
Albuterol Sulfate HfaAlbuterol Sulfate75$3,114
Celecoxib92$3,048

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$15$48,09771 claims
Novo NordiskOzempic$191$41,66334 claims
GSKTrelegy Ellipta$17$23,86222 claims
Astellas Pharma US IncMyrbetriq$14$14,74522 claims
AstraZenecaBreztri Aerosphere, Symbicort$68$13,73825 claims
AbbVieSynthroid$32$1,21523 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Stillwater

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →